Q4 2024 · 13F-HR
Nan Fung Group Holdings Ltdholdings as filed
Filed 2025-02-13 · accession 0001012975-25-000083
$116.9M
Reported value
35
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 452327109 | ILMN | ILLUMINA INC | $15.9M | 13.6% | 119,196 | Common | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $12.7M | 10.8% | 368,665 | Common | SOLE |
| H5870P102 | OCS | OCULIS HOLDING AG | $7.4M | 6.34% | 436,378 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $6.2M | 5.28% | 133,040 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $6.2M | 5.26% | 235,000 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $5.2M | 4.43% | 125,330 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $5.0M | 4.32% | 120,038 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $4.9M | 4.16% | 1,373,550 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $4.6M | 3.96% | 67,022 | Common | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $4.5M | 3.84% | 664,610 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $4.2M | 3.58% | 106,680 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $3.9M | 3.33% | 321,746 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $3.8M | 3.25% | 187,090 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $3.7M | 3.16% | 19,997 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $3.6M | 3.06% | 79,650 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $3.4M | 2.94% | 11,122 | Common | SOLE |
| 34385P108 | LAB | STANDARD BIOTOOLS INC | $3.3M | 2.82% | 1,883,179 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $2.7M | 2.35% | 49,120 | Common | SOLE |
| 30161Q104 | EXEL | EXELIXIS INC | $2.1M | 1.83% | 64,200 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $1.9M | 1.62% | 102,984 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $1.9M | 1.60% | 13,600 | Common | SOLE |
| 781154109 | RBRK | RUBRIK INC. | $1.6M | 1.36% | 24,338 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $1.3M | 1.12% | 154,522 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $1.2M | 1.06% | 30,875 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $965,202 | 0.83% | 68,943 | Common | SOLE |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $848,628 | 0.73% | 49,082 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $842,126 | 0.72% | 19,253 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $834,577 | 0.71% | 463,654 | Common | SOLE |
| 753018100 | RANI | RANI THERAPEUTICS HLDGS INC | $676,210 | 0.58% | 493,584 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $624,436 | 0.53% | 1,166,952 | Common | SOLE |
| 09769B107 | — | BOLT PROJS HLDGS INC | $391,361 | 0.33% | 811,952 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $264,450 | 0.23% | 430 | Common | SOLE |
| 23306J309 | DBVT | DBV TECHNOLOGIES S A | $114,624 | 0.10% | 37,095 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $70,057 | 0.06% | 41,950 | Common | SOLE |
| N01045207 | AFMDQ | AFFIMED N V | $44,324 | 0.04% | 37,247 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.